Studies on Tissue and Cellular Distribution of Indoleamine 2,3-Dioxygenase 2: The Absence of IDO1 Upregulates IDO2 Expression in the Epididymis

被引:64
|
作者
Fukunaga, Masakazu [1 ,2 ]
Yamamoto, Yasuko [1 ,2 ]
Kawasoe, Misaki [1 ,2 ]
Arioka, Yuko [1 ,2 ]
Murakami, Yuki [1 ,2 ]
Hoshi, Masato [3 ]
Saito, Kuniaki [1 ,2 ]
机构
[1] Kyoto Univ, Grad Sch Med, Kyoto 6068507, Japan
[2] Kyoto Univ, Fac Med, Kyoto 6068507, Japan
[3] Suzuka Univ Med Sci, Suzuka, Japan
关键词
indoleamine; 2; 3-dioxygenase; 1; epididymis;
D O I
10.1369/0022155412458926
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Indoleamine 2,3-dioxygenase 1 (IDO1) catabolizes tryptophan to kynurenine at the first step of tryptophan metabolism. Recently, in addition to IDO1, a new isoform called IDO2 was identified. In this study, we examined the tissue expression pattern of IDO2 mRNA and the cellular localization of expressed IDO2 protein in mice. IDO1 mRNA expression was observed in the colon and epididymis, whereas IDO2 mRNA expression was found in the cerebral cortex, liver, kidney, and epididymis. Immunohistochemical analysis revealed that IDO2 protein was exclusively expressed on the hepatocytes, interlobular bile ducts, neuronal cells of the cerebrum cortex, Purkinje cells of the cerebellum cortex, lamina epithelialis, proximal convoluted tubule, and the collecting tubule of the kidney. In the epididymis, IDO1 protein expression was restricted to the caput, whereas IDO2 protein expression was observed on the caput, corpus, and cauda. Both IDO proteins were expressed on the caput, but both showed a different protein expression pattern in the segments. Immunohistochemical analysis in IDO1-/- mouse epididymis showed that IDO2 protein was extensively upregulated due to the loss of IDO1 expression. (J Histochem Cytochem 60:854-860, 2012)
引用
收藏
页码:854 / 860
页数:7
相关论文
共 50 条
  • [41] Indoleamine 2,3-dioxygenase (IDO) inhibitors and cancer immunotherapy
    Fujiwara, Yu
    Kato, Shumei
    Nesline, Mary K.
    Conroy, Jeffrey M.
    DePietro, Paul
    Pabla, Sarabjot
    Kurzrock, Razelle
    CANCER TREATMENT REVIEWS, 2022, 110
  • [42] Indoleamine 2,3-dioxygenase (IDO) in inflammation and allergy to Aspergillus
    Romani, Luigina
    Zelante, Teresa
    De Luca, Antonella
    Bozza, Silvia
    Bonifazi, Pierluigi
    Moretti, Silvia
    D'Angelo, Carmen
    Giovannini, Gloria
    Bistoni, Francesco
    Fallarino, Francesca
    Puccetti, Paolo
    MEDICAL MYCOLOGY, 2009, 47 : S154 - S161
  • [43] Comparative Studies of Human Indoleamine 2,3-Dioxygenase (IDO) and Tryptophan Dioxygenase (TDO)
    Yeh, Syun-Ru
    Lewis-Ballester, Ariel
    Karkashon, Shay
    BIOPHYSICAL JOURNAL, 2012, 102 (03) : 467A - 467A
  • [44] Progesterone decreased indoleamine 2,3-dioxygenase 1(IDO1) expression in early pregnancy chorionic villi and decidua
    Yang, Minyan
    Huang, Guanyou
    Qian, Hua
    Wang, Jun
    Zhao, Shuyun
    Li, Shixiang
    Yuan, Yan
    AUTOIMMUNITY, 2021, 54 (03) : 156 - 162
  • [45] Synthesis and Molecular Modeling Studies of N′-Hydroxyindazolecarboximidamides as Novel Indoleamine 2,3-Dioxygenase 1 (IDO1) Inhibitors
    Lee, Dong-Ho
    Lee, Joo-Youn
    Jeong, Jieun
    Kim, Miok
    Lee, Kyung Won
    Jang, Eunseo
    Ahn, Sunjoo
    Lee, Chang Hoon
    Hwang, Jong Yeon
    MOLECULES, 2017, 22 (11):
  • [46] The Interplay between Indoleamine 2,3-Dioxygenase 1 (IDO1) and Cyclooxygenase (COX)-2 In Chronic Inflammation and Cancer
    Cesario, A.
    Rocca, B.
    Rutella, S.
    CURRENT MEDICINAL CHEMISTRY, 2011, 18 (15) : 2263 - 2271
  • [47] The Indoleamine-2,3-Dioxygenase (IDO) Inhibitor 1-Methyl-D-tryptophan Upregulates IDO1 in Human Cancer Cells
    Opitz, Christiane A.
    Litzenburger, Ulrike M.
    Opitz, Uta
    Sahm, Felix
    Ochs, Katharina
    Lutz, Christian
    Wick, Wolfgang
    Platten, Michael
    PLOS ONE, 2011, 6 (05):
  • [48] Discovery and Characterisation of Dual Inhibitors of Tryptophan 2,3-Dioxygenase (TDO2) and Indoleamine 2,3-Dioxygenase 1 (IDO1) Using Virtual Screening
    Sari, Suat
    Tomek, Petr
    Leung, Euphemia
    Reynisson, Johannes
    MOLECULES, 2019, 24 (23):
  • [49] Indoleamine 2,3-dioxygenase (IDO) expression and malignant transformation in prostate cancer
    Provenzano, M.
    Feder-Mengus, C.
    Wyler, S.
    Hudolin, T.
    Ruszat, R.
    Weber, W. P.
    Sulser, T.
    Bachmann, A.
    Heberer, M.
    Spagnoli, G. C.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [50] High-throughput fluorescence-based screening assay for indoleamine 2,3-dioxygenase 2 (IDO2)
    Willemsen-Seegers, N.
    van der Leeuw, S.
    Ytsma, J.
    Grobben, Y.
    Zaman, G.
    EUROPEAN JOURNAL OF CANCER, 2024, 211 : S101 - S101